Molecular Aspects of Hepatocellular Carcinoma Caused by Hepatitis C Virus

Authors

Ali Karami1,*, Seyed Moayed Alavian2, Ali Najafi2, Mohammad Javad Hosseini2
1Research Center of Molecular biology, Baqiyatallah University of Medical Sciences, [email protected], Tehran, IR.Iran
2Liver and Gastroentestinal Research Center, Baqiyatallah University of Medical Sciences and Tehran Hepatitis Center, Tehran, IR.Iran
*Corresponding Author: Research Center of Molecular biology, Baqiyatallah University of Medical Sciences, [email protected], Tehran, IR.Iran. Tel: +98 21 88039883. Fax: +98 21 88057023. Email: [email protected]

Hepatitis Monthly:Vol. 6, issue 2; 75-82
Published online:Dec 31, 2006
Article type:Review Article
Received:May 12, 2006
Accepted:May 25, 2006
How to Cite:Karami A, Alavian S, Najafi A, Hosseini M. Molecular Aspects of Hepatocellular Carcinoma Caused by Hepatitis C Virus. Hepat Mon. 2006;6(2):. doi:

Abstract

The hepatitis C virus (HCV) is a small, enveloped, single-stranded positive sense RNA virus with a diameter of about 50 nm belonging to the Hepacivirus genus of the family Flaviviridae. The HCV genome is translated to produce a single protein of around 3011 amino acids. This "polyprotein" is then proteolytically processed by viral and cellular proteases to produce structural (core protein, envelope glycoproteins E1 and E2, ARFP/F protein, p7) and nonstructural (NS2-3 autoprotease, NS3-4A, NS4B, NS5A, NS5B) proteins. Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors worldwide, with increasing incidence. It is estimated that approximately 300-400 thousands of people in the IRAN and 4 million in the United States are persistently infected. It is important for tumor control to identify the factors that predispose patients to death. A large number of molecular factors have been shown to associate with the invasiveness of HCC, and have potential prognostic significance.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

20
Oct
2012

Effects of Antiviral Therapy on the Recurrence of Hepatocellular Carcinoma After Curative Resection or Liver Transplantation

Yan Du,
Tong Su,
Yibo Ding,
Guangwen Cao

Du Y, Su T, Ding Y, Cao G. Effects of Antiviral Therapy on the Recurrence of Hepatocellular Carcinoma After Curative Resection or Liver Transplantation. Hepat Mon. 2012;12(10):6031. doi: https://doi.org/10.5812/hepatmon.6031

25
Oct
2012

Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences

Jennifer Ng,
Jennifer Wu

Ng J, Wu J. Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences. Hepat Mon. 2012;12(10):7635. doi: https://doi.org/10.5812/hepatmon.7635

30
Apr
2011

The differences in gene expression profile induced by genotype 1b hepatitis C virus core isolated from liver tumor and adjacent non-tumoral tissue

Xue-bing Yan,
Zhi Chen,
Christian Brechot

Yan X, Chen Z, Brechot C. The differences in gene expression profile induced by genotype 1b hepatitis C virus core isolated from liver tumor and adjacent non-tumoral tissue. Hepat Mon. 2011;11(4):. doi:

3
Jul
2013

Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study

Jamal Sarvari,
Zahra Mojtahedi,
Seyed Ali Reza Taghavi,
Yasuhiro Kuramitsu,
Mahmoud Shamsi Shahrabadi,
Abbas Ghaderi
,et al.

Sarvari J, Mojtahedi Z, Taghavi SAR, Kuramitsu Y, Shamsi Shahrabadi M, et al. Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study. Hepat Mon. 2013;13(7):e8351. doi: https://doi.org/10.5812/hepatmon.8351

31
Jan
2012

Clinical Features of Hepatitis C Virus Carriers With Persistently normal Alanine Aminotransferase Levels

Hirofumi Uto,
Hirofumi Uto,
Seiich Mawatari,
Seiich Mawatari,
Kotaro Kumagai,
Kotaro Kumagai
,et al.

Uto H, Uto H, Mawatari S, Mawatari S, Kumagai K, et al. Clinical Features of Hepatitis C Virus Carriers With Persistently normal Alanine Aminotransferase Levels. Hepat Mon. 2012;12(2):. doi: https://doi.org/10.5812/hepatmon.829

More by these authors

Ali KaramiPubMedScholar
Seyed AlavianPubMedScholar
Ali NajafiPubMedScholar
Mohammad HosseiniPubMedScholar
Share
Cited by
Metrics